Synaptiq
PrivateLast Round
Late Seed
Jul 6, 2026
Est. Valuation
$5.85M
Total Funding Raised
$1.26M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Synaptiq is a healthcare technology company that develops AI-powered software to automate the contouring of tumors and organs at risk for radiotherapy treatment planning.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synaptiq Comparables
Compare Synaptiq with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MVision AI | 89% | |
| TheraPanacea | 88% | |
| Oncosoft | 86% | |
Synaptiq Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Late Seed | Jul 6, 2026 | ||||
| Accelerator | Apr 23, 2026 | ||||
| Grant | Dec 20, 2023 | ||||
| Seed | Apr 4, 2023 | ||||
| Grant | Aug 29, 2022 | ||||
Pre Seed | Oct 19, 2021 |
Key People
Founding team and executive leadership
Synaptiq Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Accelerator |
| GapMinder Venture Partners | Pre Seed |
| Cleverage Venture Capital | Pre Seed, Seed |
| Fortech Investments | Seed |
| Innovasjon Norge | Grant |
| Cleverage Venture Capital | Pre Seed, Seed |
| SeedBlink | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 149% MoM.
- Jul 6, 2026
Raised $3.4M in a Late Seed round.
Synaptiq Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Synaptiq's valuation, stock price, and market status.